Abstract:Dysregulation of antigen receptor-mediated signaling contributes to the oncogenesis of lymphoid malignancies. The activated B cell-like (ABC) subtype of Diffuse Large B cell Lymphoma (DLBCL) is characterized by receptor-independent constitutive activation of the canonical nuclear factor-kappaB (NF-κB) pathway, which is essential for the proliferation and survival of tumor cells. Caspase recruitment domain-containing protein 11 (CARD11) is a scaffolding protein that regulates B and T cell receptor signaling to canonical NF-κB activation downstream for adaptive immune response. Oncogenic gain-of-function (GOF) CARD11 mutations bypass normal pathway regulation and result in a hyperactive CARD11 that signals constitutively. Although present in ~10% of human ABC-DLBCL biopsies, we do not have a complete mechanistic understanding of how CARD11 GOF mutations drive abnormal B cell proliferation to cause lymphoma. We generated a mouse expressing the DLBCL-associated GOF mutation C49Y from the endogenous CARD11 locus. GOF CARD11 was sufficient to specifically drive B cell expansion in the mice with no significant effect on CD4+ or CD8+ T cells or NK cells. Quantification of splenic lymphocytes revealed that CARD11C49Y/C49Y mice had ~5-fold more splenic B cells when compared to CARD11+/+ mice and ~13-fold more marginal zone (MZ) B cells. CARD11C49Y/C49Y MZ B cells proliferated and survived much better than CARD11+/+ following stimulation with αIgM and importantly exhibited significant survivability prior to stimulation. Bulk mRNA sequencing revealed genes uniquely dysregulated in CARD11C49Y/C49Y MZ B cells including those associated with non-canonical NF-κB pathway signaling. CARD11C49Y/C49Y MZ B cells exhibited elevated levels of the p100 precursor NF-kB subunit leading to enhanced production of nuclear p52 following BAFF treatment. CARD11C49Y/C49Y MZ B cells also exhibited elevated levels of TRAF2, TRAF3 and cIAP1/2, components of a complex that degrades the NIK kinase that is responsible in normal cells for inducing p100 processing. Our results reveal an unexpected ability of CARD11 GOF mutants to potentiate the non-canonical NF-κB pathway through p100 accumulation, which likely contributes to the dysregulated B cell expansion observed in DLBCL cases that harbor CARD11 GOF variants. Citation Format: Anushka Ghosh, Joel Pomerantz. Oncogenic CARD11 enhances marginal zone B cell survival by potentiating the non-canonical NF-κB pathway [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6986.

Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy

A novel CARD11 germline mutation in a Chinese patient of B cell expansion with NF-κB and T cell anergy (BENTA) and literature review

Pathogenic CARD11 Mutations Affect B Cell Development and Differentiation Through a Noncanonical Pathway

A new-disease-causing dominant-negative variant in CARD11 gene in a Chinese case with recurrent fever

Abstract 6986: Oncogenic CARD11 enhances marginal zone B cell survival by potentiating the non-canonical NF-κB pathway

A Novel RFXANK Mutation in a Chinese Child with MHC II Deficiency: Case Report and Literature Review

Subcutaneous panniculitis-like T-cell lymphoma in two unrelated individuals with BENTA disease

CARD11 regulates the thymic Treg development in an NF-κB-independent manner

Clinical and Genetic Characteristics of <i>IKZF1</i> Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia

Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency

Further Delineation of Primary B Cell Immunodeficiency Caused by Novel Variants of the BLNK Gene in Two Chinese Patients.

Intrinsic Functional Defects in B Cells of Patients with NFKB2 Mutations

A heterozygous N-terminal truncation mutation of NFKBIA results in an impaired NF-κB dependent inflammatory response

A heterozygous N-terminal truncation mutation of <i>NFKBIA</i> results in an impaired NF-B dependent inflammatory response

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease

Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant

A Heterozygous Nonsense Variant of NFKBIA Leading to Gain-of-Function

Combined immunodeficiency caused by a novel homozygous NFKB1 mutation

Antibody Deficiency Associated with an Inherited Autosomal Dominant Mutation in TWEAK

Novel Heterogeneous Mutation of TNFAIP3 in a Chinese Patient with Behçet-Like Phenotype and Persistent EBV Viremia